63674-63-5

Usage

Uses

Used in Pharmaceutical Industry:
1-(3,5-DIMETHYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID is used as a potential pharmaceutical compound for its unique structural features and chemical properties. Its complex structure may allow it to interact with biological targets in novel ways, offering new avenues for drug development and therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(3,5-DIMETHYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID can serve as a building block or intermediate in the synthesis of more complex organic molecules. Its reactive functional groups may facilitate the formation of new chemical bonds and the creation of a variety of derivative compounds.
Used in Material Science:
1-(3,5-DIMETHYLPHENYL)-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID may also find applications in material science, where its unique structure and properties could contribute to the development of new materials with specific characteristics. Its potential use in this field could include the creation of polymers, coatings, or other materials with tailored properties for various applications.

Upstream product

• 97-65-4 2-methylenesuccinic acid 
• 108-69-0 3,5-dimethylaminoaniline 

Downstream Products

• 133748-16-0 methyl 1-(3,5-dimethylphenyl)-5-oxo-3-pyrrolidinecarboxylate 
• 133748-17-1 1-(3,5-Dimethylphenyl)-4-hydroxymethyl-2-pyrrolidone 
• 1026530-73-3 Methanesulfonic acid 1-(3,5-dimethyl-phenyl)-5-oxo-pyrrolidin-3-ylmethyl ester 
• 133748-18-2 Methyl 4-[1-(3,5-dimethylphenyl)-2-pyrrolidon-4-yl]methoxybenzoate 

Relevant academic research and scientific papers

Synthesis of 4-methyloxybenzoic acids and related compounds, and their inhibitory capacities toward fatty-acid and sterol biosynthesis

The synthesis of a series of 4-methyloxybenzoic acids and related compounds, and their evaluation for inhibitory capacity toward fatty-acid and sterol biosyntheses using rats' liver slices in vitro and rabbits

Phenylcarboxylic acid derivatives having hetero ring

Phenylcarboxylic acid derivatives having a hetero ring in the substituent of the formula: STR1 wherein R1 is halogen, alkyl, cycloalkyl, hydroxy, alkoxy, phenoxy which has a substituent selected from halogen and alkyl, carboxyl, alkylsulfonyloxy, phenylsulfonyloxy optionally substituted by halogen, alkylsulfonyloxyalkoxy, amino, alkanoylamino, benzoylamino, alkenyloxy, phenylalkoxyalkoxy, hydroxyalkoxy, phenylalkoxy having optionally 1 to 3 substituents selected from halogen, alkyl and alkoxy, halogenoalkyl, cycloalkyloxy optionally substituted by hydroxy, alkoxy substituted by cycloalkyl having optionally hydroxy substituent, imidazolylalkyl or imidazolylalkoxy; k is 0 or 1 to 3; or (R1)k is alkylenedioxy; A is alkylene or alkylenoxy; l is 0 or 1; B is methylene or carbonyl; m is 0 or 1; D is alkylene; E is alkylene or alkenylene; n is 0 or 1; and R2 is hydrogen or alkyl, or a salt thereof, which have fatty acid synthesis-inhibitory activity, cholesterol synthesis-inhibitory activity and are useful as antilipidemic agent, prophylactic and treating agent of arteriosclerosis, prophylactic and treating agent of obesity, antidiabetics.